These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 28724614)

  • 21. TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins.
    Bhansali M; Zhou J; Shemshedini L
    Mol Endocrinol; 2016 Jan; 30(1):13-25. PubMed ID: 26649804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of GPR56, a novel adhesion GPCR, is necessary for nuclear androgen receptor signaling in prostate cells.
    Singh JP; Dagar M; Dagar G; Kumar S; Rawal S; Sharma RD; Tyagi RK; Bagchi G
    PLoS One; 2020; 15(9):e0226056. PubMed ID: 32881870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.
    Jin Y; Qu S; Tesikova M; Wang L; Kristian A; Mælandsmo GM; Kong H; Zhang T; Jerónimo C; Teixeira MR; Yuca E; Tekedereli I; Gorgulu K; Alpay N; Sood AK; Lopez-Berestein G; Danielsen HE; Ozpolat B; Saatcioglu F
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):E2572-81. PubMed ID: 23798432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism.
    Poluri RTK; Paquette V; Allain ÉP; Lafront C; Joly-Beauparlant C; Weidmann C; Droit A; Guillemette C; Pelletier M; Audet-Walsh É
    Endocr Relat Cancer; 2021 Apr; 28(4):257-271. PubMed ID: 33690159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PI3K-AKT-mTOR signaling in prostate cancer progression and androgen deprivation therapy resistance.
    Edlind MP; Hsieh AC
    Asian J Androl; 2014; 16(3):378-86. PubMed ID: 24759575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate.
    Bryant KG; Camacho J; Jasmin JF; Wang C; Addya S; Casimiro MC; Fortina P; Balasubramaniam S; Knudsen KE; Schwarting R; Lisanti MP; Mercier I
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1318-29. PubMed ID: 21601007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.
    Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS
    Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
    Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
    Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors.
    Xie N; Cheng H; Lin D; Liu L; Yang O; Jia L; Fazli L; Gleave ME; Wang Y; Rennie P; Dong X
    Int J Cancer; 2015 Feb; 136(4):E27-38. PubMed ID: 25138562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The mechanisms of prostate cancer progression through androgen receptor].
    Goto Y; Sakamoto S; Ichikawa T
    Nihon Rinsho; 2016 Jan; 74(1):55-9. PubMed ID: 26793880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
    Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Castration-resistant prostate cancer: locking up the molecular escape routes.
    Attar RM; Takimoto CH; Gottardis MM
    Clin Cancer Res; 2009 May; 15(10):3251-5. PubMed ID: 19447877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
    Shiota M; Yokomizo A; Naito S
    Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clock gene BHLHE40 and atypical CCNG2 control androgen-induced cellular senescence as a novel tumor suppressive pathway in prostate cancer.
    Heidari Horestani M; Atri Roozbahani G; Baniahmad A
    J Exp Clin Cancer Res; 2024 Jun; 43(1):174. PubMed ID: 38902772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of androgens and the androgen receptor in prostate cancer.
    Debes JD; Tindall DJ
    Cancer Lett; 2002 Dec; 187(1-2):1-7. PubMed ID: 12359344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells.
    Safi R; Wardell SE; Watkinson P; Qin X; Lee M; Park S; Krebs T; Dolan EL; Blattler A; Tsuji T; Nayak S; Khater M; Fontanillo C; Newlin MA; Kirkland ML; Xie Y; Long H; Fink EC; Fanning SW; Runyon S; Brown M; Xu S; Owzar K; Norris JD; McDonnell DP
    Nat Commun; 2024 Sep; 15(1):7675. PubMed ID: 39227594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.
    Takayama K; Misawa A; Suzuki T; Takagi K; Hayashizaki Y; Fujimura T; Homma Y; Takahashi S; Urano T; Inoue S
    Nat Commun; 2015 Sep; 6():8219. PubMed ID: 26404510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
    Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ
    Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
    Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
    Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.